| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |